---
title: Activity Daily Living Performance in Patients With Stroke
nct_id: NCT03723213
overall_status: UNKNOWN
sponsor: Kocaeli University
study_type: OBSERVATIONAL
primary_condition: Stroke
countries: Turkey (Türkiye)
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03723213.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03723213"
ct_last_update_post_date: 2019-02-15
last_seen_at: "2026-05-12T06:54:59.285Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Activity Daily Living Performance in Patients With Stroke

**Official Title:** Investigation of Activity Daily Living Performance in Patients With Chronic Stroke

**NCT ID:** [NCT03723213](https://clinicaltrials.gov/study/NCT03723213)

## Key Facts

- **Status:** UNKNOWN
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 26
- **Lead Sponsor:** Kocaeli University
- **Conditions:** Stroke
- **Start Date:** 2018-10-24
- **Completion Date:** 2019-10-11
- **CT.gov Last Update:** 2019-02-15

## Brief Summary

In the rehabilitation of stroke patients, the emphasis is on the treatment of physical pathologies such as increased range of motion and muscle strength, reduction of spasticity and pain. All these treatments provide increased physical capacity of the patient. But these are not enough for perform the activity daily living. In order to be successful in activity daily living of the patient, performance based treatment methods should also be applied.

The use of Canadian Occupational Performance Measurement (COPM), which measures patients' defined problem areas in daily practice should contribute to the patient-oriented approach process.

## Detailed Description

In the rehabilitation of stroke patients, the emphasis is on the treatment of physical pathologies such as increased range of motion and muscle strength, reduction of spasticity and pain. All these treatments provide increased physical capacity of the patient. But these are not enough for perform the activity daily living. In order to be successful in activity daily living of the patient, performance based treatment methods should also be applied.

The use of Canadian Occupational Performance Measurement (COPM), which measures patients' defined problem areas in daily practice should contribute to the patient-oriented approach process.The Canadian Occupational Performance Measure (COPM) is an important tool to enable personalized health care.One of the strengths of the measure is its broad focus on occupational performance in all areas of life, including self-care, leisure and productivity, taking into account development throughout the lifespan and the personal life circumstances.

COPM has been described as having various advantages in terms of increasing applicability, responsibility and motivation for occupational therapy.There are two focus points in the COPM. The first one is the person-centered; the second is activity performance appropriate to the person's wishes.

By using conventional methods in stroke rehabilitation, contractures and deformities that may occur in patients can be reduced, muscle strength can be increased, and inadequate gait failure in patients can be minimized.

However, in many activities needed for daily living activities, the patient is able to sustain his inadequacy such as dressing, eating, bathing, going to the store. With the application of COPM, deficiencies in patients and the most important needs can be emphasized; thus, a program can be prepared during the treatment process. As the COPM test is a patient-centered test, it has an important place in occupational therapy programs.

In this study, Frenchay Activities Index, Barthel ADL Index and COPM will be applied in order to focus on the performances that stroke patients need in their daily living activities and to improve the independence of the patients and to emphasize patient-focused treatment. After the tests are applied, the rehabilitation process will be conducted by a treatment plan according to the needs of the patients.After the treatments, the tests will be repeated and the success rate will be evaluated on the patients.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 65 Years
- **Sex:** ALL

```
Inclusion Criteria:

* Being 18 between 65 years of age,
* To be volunteer,
* Stability of medical conditions of patients,
* Have a sufficient communication skills,
* There will be not severe pain that will affect the treatment
* At least three months after cerebrovascular disease,
* Hemiplegia depends on cerebrovascular disease
* There will be not serious cognitive defect \[Mini Mind Test (MMT) score of 24 and above\],
* The patients have to have Stage of Brunnstrom is III or more appropriate,
* Modified Ashworth Scale (MAS) score has to be 2 and below
* Independent seating balance

Exclusion Criteria:

* To be an acute term stroke
* Patient consciousness is closed,
* Having a history of stroke before,
* Having a history of spinal cord lesion, traumatic brain injury, other accompanying neurological disease (multiple sclerosis, Parkinson's disease, dementia) or lower motor neuron disease,
* Having a history of tumor, convulsion,
* An important comorbid disease, such as severe heart disease (aortic stenosis, angina, arrhythmia, pacemaker) and uncontrolled hypertension, which may prevent rehabilitation, epileptic seizure history,
* No volunteer
* Excessive spasticity in the affected upper extremity joints (shoulder, elbow, wrist, fingers) \[Modified Ashworth Scale (MAS) score is ≥ 3,
* Lack of sitting balance
```

## Primary Outcomes

- **canadian occupational performance measure (COPM)** _(time frame: 3 weeks interval)_ — COPM has a client-centered design and measures outcomes according to three occupational performance areas (self-care, productivity, and leisure), examining self-perceived changes in the occupational performance of patients through a semistructured interview. The COPM prompts discussion between interviewees and therapists on factors such as different areas of activity, their concerns, and problems to be resolved. At the beginning, patients start by identifying their difficulties according to the three occupational performance areas. They subsequently use a 10-point Likert-type scale, ranging from not at all crucial (1) to extremely crucial (10), to identify the intensity of certain difficulties. For the top five problems or tasks selected by patients, the interviewer asks them to continue identifying their performance and satisfaction with their performance by using the same 10-point rating scale. Accordingly, therapists focus on these main problems or tasks.

## Secondary Outcomes

- **Modified Ashworth Scale (MAS)** _(time frame: 3 weeks interval)_
- **Brunnstrom's Hemiplegia Recovery Staging** _(time frame: 3 weeks interval)_
- **Mini Mental Stage Examination** _(time frame: 3 weeks interval)_
- **The Barthel Activity Daily Living Index** _(time frame: 3 weeks interval)_
- **The Frenchay Activities Index (FAI)** _(time frame: 3 weeks interval)_

## Locations (2)

- Cigdem Cekmece, Kocaeli, İzmit, Turkey (Türkiye) — _RECRUITING_
- Cigdem Cekmece, Kocaeli, Yahya Kaptan, Turkey (Türkiye) — _NOT_YET_RECRUITING_

## Recent Field Changes (last 30 days)

- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.cigdem cekmece|kocaeli|i̇zmit|turkey (türkiye)` — added _(2026-05-12)_
- `locations.cigdem cekmece|kocaeli|yahya kaptan|turkey (türkiye)` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03723213.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03723213*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*